Concepedia

Yumiko Hirokawa

YH

33

Publications

1.5K

Citations

24

H-Index

1985

Active since

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Ludwig Cancer Research

The Royal Melbourne Hospital

Monash University

Yumiko Hirokawa is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1985–2023

33

Publications

33

Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Mayur Garg, Simon G. Royce, Chris Tikellis et al. · Gut · 2019 · 207 citations

Wnt Signalling Pathway Parameters for Mammalian Cells

Chin Wee Tan, Bruce S. Gardiner, Yumiko Hirokawa et al. · PLoS ONE · 2012 · 132 citations · Full text

A Clue to the Therapy of Neurofibromatosis Type 2

Yumiko Hirokawa, Anjali Tikoo, John Huynh et al. · The Cancer Journal · 2004 · 101 citations

Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance

Yumiko Hirokawa, Melissa Wervey Arnold, Hidenori Nakajima et al. · Cancer Biology & Therapy · 2005 · 80 citations · Full text

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

Zilu Wang, Matteo Burigotto, Sabrina Ghetti et al. · Cancer Discovery · 2023 · 79 citations · Full text

Rows per page

1–5 of 33